PTPRC and rheumatoid arthritis: Lee et al. performed a meta-analysis using eight studies with a total of 3058 patients, and they demonstrated that PTPRC polymorphisms result in poor response to anti-TNF therapy in treatment of rheumatoid arthritis [20].